These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 4803477)

  • 1. [On the specifity of human serum paraoxonase (author's transl)].
    Geldmacher-von Mallinckrodt M; Pétényi M; Flügel M; Burgis H; Dietzel B; Metzner H; Nirschl H; Renner O
    Hoppe Seylers Z Physiol Chem; 1973 Mar; 354(3):337-40. PubMed ID: 4803477
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Letter: Comments in response to genetically determined polymorphism of human serum paraxonase (EC 3.1.1.2) (author's transl)].
    Geldmacher Mallinckrodt ; Lindorf HH; Petenyi M; Flügel M; Fischer T; Hiller T
    Humangenetik; 1973 Sep; 19(3):353-6. PubMed ID: 4763943
    [No Abstract]   [Full Text] [Related]  

  • 4. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetically determined polymorphism of human serum paraoxonase (EC 3.1.1.2)].
    Geldmacher-von Mallinck ; Lindorf HH; Petenyi M; Flügel M; Fischer T; Hiller T
    Humangenetik; 1973; 17(4):331-5. PubMed ID: 4694515
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphism and clinical significance of human paraoxonase enzyme].
    Renczes G; Róna K; Szabó I; Somogyi A
    Orv Hetil; 1997 Aug; 138(33):2057-9. PubMed ID: 9304097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Esterolytic activity of human serum (author's transl)].
    Skorepa J; Mares P; Todorovicová H
    Cas Lek Cesk; 1974 May; 113(21-22):650-2. PubMed ID: 4451948
    [No Abstract]   [Full Text] [Related]  

  • 10. [On kinetics of the paraoxon hydrolysing enzyme in human serum (EC 3.1.1.2) (author's transl)].
    Flügel M; Geldmacher-von Mallinckrodt M
    Klin Wochenschr; 1978 Sep; 56(18):911-6. PubMed ID: 713421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between human serum esterases and environmental metal compounds.
    Hernández AF; Gil F; Leno E; López O; Rodrigo L; Pla A
    Neurotoxicology; 2009 Jul; 30(4):628-35. PubMed ID: 19393262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Esterolytic activity of the blood serum in gastric cancer (author's transl)].
    Skorepa J; Bartůnĕk P; Mares P; Todorovicová H; Somorin O
    Cas Lek Cesk; 1979 Jun; 118(23):729-30. PubMed ID: 476766
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers.
    Sierksma A; van der Gaag MS; van Tol A; James RW; Hendriks HF
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1430-5. PubMed ID: 12351939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 2000 Sep; 276(2):729-33. PubMed ID: 11027539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Esterolytic activity of serum in the diagnosis of bronchogenic carcinoma (author's transl)].
    Todorovicová H
    Cas Lek Cesk; 1974 May; 113(21-22):653-6. PubMed ID: 4451949
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic mechanism of the detoxification of the organophosphate paraoxon by human serum A-esterase.
    Vitarius JA; Sultatos LG
    Drug Metab Dispos; 1994; 22(3):472-8. PubMed ID: 8070326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the determination of human serum trypsin protein esterase activity (author's transl)].
    Miyatani U; Takahata J; Fukui I
    Rinsho Byori; 1975 Jun; 23(6):423-6. PubMed ID: 1237002
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon.
    Pond AL; Chambers HW; Coyne CP; Chambers JE
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1404-11. PubMed ID: 9732404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.